FIELD: medicine.
SUBSTANCE: invention refers to diagnostic technique for septic complications in a human or other animals suffering a multiple trauma wherein said patients have no traumatic cerebral injury. Enzyme immunoassay is used to determine the level of C-type natriuretic peptide (CNP) or a C-type natriuretic peptide precursor (NT-proCNP). If the CNP or NT-proCNP level is increased as compared with the normal levels specific for the given patient, then the given patient is stated to suffer from septic complications or being at risk of developing septic complications.
EFFECT: improved diagnostic accuracy.
6 tbl, 9 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE DEVELOPMENT OF INFECTIOUS COMPLICATIONS AND SEPSIS IN PATIENTS WITH A SEVERE TRAUMATIC BRAIN INJURY | 2020 |
|
RU2743806C1 |
| METHOD FOR PREDICTION OF DEVELOPING MYOCARDIAL DYSFUNCTION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA | 2012 |
|
RU2502071C1 |
| PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE | 2013 |
|
RU2672561C2 |
| ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE | 2014 |
|
RU2673455C2 |
| METHOD FOR SEPSIS DEVELOPMENT RISK EVALUATION FOR PATIENTS WITH SEVERE CRANIOCEREBRAL TRAUMA | 2016 |
|
RU2624171C1 |
| ASSESSMENT OF PREDICTION AND RISK FOR PATIENTS WITH NONSPECIFIC COMPLAINTS | 2011 |
|
RU2618437C2 |
| PROADM FOR PREDICTING RISK OF CONDITION REQUIRING HOSPITALIZATION IN PATIENTS WITH SYMPTOMS OF INFECTIOUS DISEASE | 2019 |
|
RU2820944C2 |
| PRO-CALCITONIN FOR DIAGNOSIS OF BACTERIAL INFECTIONS AND CONTROL OF ANTIBIOTIC TREATMENT FOR PATIENTS WITH NONSPECIFIC COMPLAINTS | 2011 |
|
RU2580278C2 |
| ANTIBODY AGAINST ADRENOMEDULLIN (ADM), OR FRAGMENT OF ANTI-ADM ANTIBODY, OR ANTI-ADM NON-IG FRAME FOR USE IN INTERVENTION AND THERAPY OF HYPEREMIA IN PATIENT | 2017 |
|
RU2762059C2 |
| WAY OF DIAGNOSTICS OF DEGREE OF DISTURBANCE OF CARDIOVASCULAR SYSTEM FUNCTION AT NEWBORNS FROM GROUP WITH HIGH PERINATAL RISK | 2007 |
|
RU2363000C2 |
